We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1919:HKEXCOSCO SHIPPING Holdings Co., Ltd. Analysis

Data as of 2026-03-11 - not real-time

HK$15.78

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

COSCO SHIPPING Holdings is trading just below its DCF‑derived fair value, with the 20‑day SMA comfortably above both the 50‑day and 200‑day averages, confirming a bullish technical backdrop. The MACD line sits above its signal line and the histogram is positive, while volume is on an upward trend, reinforcing short‑term momentum. Fundamentally, the stock boasts a rock‑bottom PE relative to an industry average near 30×, a sub‑1× price‑to‑book, and an attractive 11% dividend yield supported by a payout ratio under 50% and ample cash reserves. However, revenue has contracted sharply year‑over‑year and the 30‑day volatility exceeds 30%, indicating the price could swing sharply on macro‑shipping news.
Given the combination of cheap valuation, strong dividend sustainability, and bullish technical signals, the near‑term outlook is cautiously optimistic, but investors should stay mindful of cyclical shipping demand, regulatory shifts in China, and the stock’s exposure to broader trade dynamics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA crossover, MACD bullish, rising volume)
  • High dividend yield with sustainable payout
  • Price near DCF fair value limiting upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervaluation relative to peers (low PE, low PB)
  • Recent fleet expansion order indicating future capacity growth
  • Strong cash position to weather earnings volatility

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term secular growth in global container trade
  • Exposure to Chinese and Asian shipping lanes
  • Consistent dividend income offsetting earnings volatility

Key Metrics & Analysis

Financial Health

Revenue Growth-20.40%
Profit Margin16.78%
P/E Ratio4.4
ROE15.47%
ROA5.37%
Debt/Equity26.97
P/B Ratio0.9
Op. Cash FlowHK$57.6B
Free Cash FlowHK$13.8B
Industry P/E30.0

Technical Analysis

TrendBullish
RSI63.4
SupportHK$13.70
ResistanceHK$16.60
MA 20HK$14.88
MA 50HK$14.17
MA 200HK$13.84
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

Fair ValueHK$15.89
Target PriceHK$14.08
Upside/Downside-10.78%
GradeUndervalued
TypeValue
Dividend Yield11.00%

Risk Assessment

Beta0.36
Volatility30.06%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.